Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

SIMPLE SUMMARY: Therapies selectively targeting cancer-specific defects have the advantage of minimising damage to normal tissue including the immune system. The work described here investigates a therapy that targets replication stress, a common feature of many cancer types including melanoma. We d...

Descripción completa

Detalles Bibliográficos
Autores principales: Proctor, Martina, Gonzalez Cruz, Jazmina L., Daignault-Mill, Sheena M., Veitch, Margaret, Zeng, Bijun, Ehmann, Anna, Sabdia, Muhammed, Snell, Cameron, Keane, Colm, Dolcetti, Riccardo, Haass, Nikolas K., Wells, James W., Gabrielli, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345057/
https://www.ncbi.nlm.nih.gov/pubmed/34359633
http://dx.doi.org/10.3390/cancers13153733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345057/
https://www.ncbi.nlm.nih.gov/pubmed/34359633
http://dx.doi.org/10.3390/cancers13153733

Ejemplares similares